DATAPHARM A/S: Financial statements 2025
CVR: 72323211
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
DATAPHARM A/S (CVR 72323211) has filed annual accounts for 2025. In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity in the 2025 report amounted to DKK 11,750,274. The solvency ratio was 89.9%.
- Profit/Loss
- DKK 657,407
- Equity
- DKK 11,750,274
- Total Assets
- DKK 13,065,669
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | - | 657 t. | 11.8 mio. | 0 |
| 2024 | - | - | 651 t. | 11.1 mio. | 0 |
| 2023 | - | - | 704 t. | 10.4 mio. | 0 |
| 2022 | - | - | 841 t. | 9.7 mio. | 0 |
| 2021 | - | - | 602 t. | 8.9 mio. | 0 |
Official annual report
How creditworthy is DATAPHARM A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 18, 2025, Mia Bendix Andersen has joined the board of directors of DATAPHARM A/S.
As of September 17, 2025, Jakob Bjørnholt Tjelum has left the board of directors of DATAPHARM A/S.
DATAPHARM A/S has published its annual report for 2024. The net result was DKK 650,613.
About DATAPHARM A/S
DATAPHARM A/S is a Danish company of the type Aktieselskab based in København K, founded in 1983. The company is registered under the industry Computerprogrammering. The management consists of Henrik Bruun. The board consists of Dan Asmussen (chair), Dorte Kamp Teglgård, Jonas Arendal Grønskov and Mia Bendix Andersen. The company is owned by D.A. INVEST OG UDVIKLING A/S. The company has 4 employees (2004). In 2025, the company reported a net result of DKK 657,407 compared with DKK 650,613 the year before. Equity in the 2025 report amounted to DKK 11,750,274.